CAMLINFINENSECamlin Fine Sciences LimitedHighNeutral
Announced Mon, 4 May · 22:48 IST

Camlin Fine Sciences Limited has informed the Exchange about press release issued by the Company.

Listed Co AcquisitionOpen Offer TriggeredStrategic Transactions View source PDF

CAMLINFINE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+4.1%1-day move
₹131.60
prior close
₹132.60
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-1.7-2.0-1.0+0.2+4.1+3.6+0.4-4.4-8.2-6.5-7.7+0.7+1.1
Up moveDown movePending
AI summary

Camlin Fine Sciences has filed a draft tender offer with the French Stock Markets Authority (AMF) for the remaining shares of Vinpai, a French company listed on Euronext Growth Paris. CFSL acquired a majority stake of 78.68% in Vinpai in November 2025 and now holds 83.82% of share capital after converting convertible bonds. The tender offer targets the remaining 16.18% shares at EUR 3.60 per share, the same price as the original block acquisition. Vinpai's Board of Directors has unanimously issued a favorable opinion on the offer, supported by a fairness opinion from independent expert Crowe HAF. CFSL has clarified it does not intend to implement a squeeze-out procedure.

Likely market impact

The tender offer gives minority shareholders of Vinpai an opportunity to exit at the same price as the block acquisition, providing immediate liquidity. For CFSL shareholders, this strengthens control over Vinpai without any immediate material impact on financials.